Roche Holding AG
SIX:ROG
Roche Holding AG
Long-Term Debt
Roche Holding AG
Long-Term Debt Peer Comparison
Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Roche Holding AG
SIX:ROG
|
Long-Term Debt
CHf24.8B
|
CAGR 3-Years
34%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
Novartis AG
SIX:NOVN
|
Long-Term Debt
$18.7B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
2%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Long-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Long-Term Debt
$118m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Long-Term Debt?
Long-Term Debt
24.8B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Long-Term Debt amounts to 24.8B CHF.
What is Roche Holding AG's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
4%
Over the last year, the Long-Term Debt growth was 16%. The average annual Long-Term Debt growth rates for Roche Holding AG have been 34% over the past three years , 9% over the past five years , and 4% over the past ten years .